Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
67%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
2(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Enrolling by invitation1
Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (100.0%)

Trials by Status

enrolling_by_invitation133%
completed133%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
enrolling_by_invitation

Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease

NCT06942312
recruitingphase_1

Mechanisms of Diuretic Resistance in Heart Failure, Aim 3

NCT06209359
completedphase_1

The Effects of Urinary pH Changes on an Investigational Compound in Healthy Subjects

NCT01440478

Clinical Trials (3)

Showing 3 of 3 trials
NCT06942312

Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease

Enrolling By Invitation
NCT06209359Phase 1

Mechanisms of Diuretic Resistance in Heart Failure, Aim 3

Recruiting
NCT01440478Phase 1

The Effects of Urinary pH Changes on an Investigational Compound in Healthy Subjects

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3